Literature DB >> 1116870

A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system.

W H McBride, J Dawes, N Dunbar, A Ghaffar, M F Woodruff.   

Abstract

Various strains of anaerobic coryneforms and the closely related Propionibacteria have been compared in vivo with respect to their anti-tumour activity. Their effectiveness has been correlated with their serological relationship and to some extent with their ability to stimulate the lymphoreticular system. Organisms belonging to Corynebacterium acnes groups I and II and C. avidum group IV were active anti-tumour agents, although of varying effectiveness. These strains are serologically closely related and all produce a soluble cross-reacting antigen. The single C. granulosum group III strain which we tested, an unclassified coryneform, and the classical Propionibacteria did not cross-react with the main group and had little or no anti-tumour activity. At the high dose (0.7 mg) we used, all strains, whether they inhibited tumour development or not, enhanced clearance of colloidal carbon and stimulated production of an inflammatory peritoneal exudate; at lower dosage the results were too variable to permit valid comparison. At the higher dose anti-tumour activity of a strain appeared to correlate best with ability to produce splenomegally and decrease red cell volume in the blood.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116870      PMCID: PMC1445762     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  [STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM].

Authors:  B N HALPERN; A R PREVOT; G BIOZZI; C STIFFEL; D MOUTON; J C MORARD; Y BOUTHILLIER; C DECREUSEFOND
Journal:  J Reticuloendothel Soc       Date:  1964-01

2.  The Taxonomic Position of Corynebacterium acnes.

Authors:  H C Douglas; S E Gunter
Journal:  J Bacteriol       Date:  1946-07       Impact factor: 3.490

3.  [Quantitative study of the granulopectic activity of the reticuloendothelial system of mice].

Authors:  G BIOZZI; B BENACERRAF; C STIFFEL; B N HALPERN
Journal:  C R Seances Soc Biol Fil       Date:  1954-03

4.  Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.

Authors:  M F Woodruff; W H McBride; N Dunbar
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

5.  Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages.

Authors:  P C Wilkinson; G J O'Neill; K G Wapshaw
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

6.  The role of anaerobic coryneforms on specific and non-specific immunological reactions. I. Effect on particle clearance and humoral and cell-mediated immunological responses.

Authors:  G J O'Neill; D C Henderson; R G White
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

7.  Immunostimulation-inhibition of tumor cell growth in vitro utilizing tumor target cells labeled with 125I-iodo-deoxyuridine.

Authors:  I J Fidler
Journal:  Immunol Commun       Date:  1973

8.  The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum.

Authors:  M Woodruff; N Dunbar; A Ghaffar
Journal:  Proc R Soc Lond B Biol Sci       Date:  1973-08-31

9.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

10.  Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.

Authors:  I Parr; E Wheeler; P Alexander
Journal:  Br J Cancer       Date:  1973-05       Impact factor: 7.640

View more
  8 in total

Review 1.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

2.  Effects of intravenous injection of two different strains of Corynebacterium parvum in the mouse.

Authors:  T E Sadler; P D Jones; J E Castro; I A Lampert
Journal:  Br J Exp Pathol       Date:  1979-12

3.  Paradoxical presence of T cell anergy during successful T cell-dependent tumour immunotherapy: characterization of a state of T cell 'amnaesia' following systemic administration of C. parvum.

Authors:  W H McBride; S Howie
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

4.  Isolation of an acidic polysaccharide antigen from Propionibacterium acnes.

Authors:  O J Iversen; A B Dalen; H B Svindland
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

5.  The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity.

Authors:  W Roszkowski; H L Ko; K Roszkowski; S Szmigielski; J Jeljaszewicz; G Pulverer
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

6.  Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.

Authors:  M F Woodruff; N Dunbar
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

7.  Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma.

Authors:  S Szymaniec; K James
Journal:  Br J Cancer       Date:  1976-01       Impact factor: 7.640

8.  Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect.

Authors:  H D Mitcheson; T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.